Acquisition (action)
Grünenthal Expands US Presence with $250 Million Acquisition of Valinor Pharma and Movantik
Grünenthal, Valinor Pharma, Movantik, Acquisition, US Expansion, Pharmaceutical Industry
Johnson & Johnson Raises 2024 Guidance Following Acquisition of Shockwave Medical
Johnson & Johnson, Shockwave Medical, 2024 Guidance, Acquisition, Billion-Dollar Potential
Lilly Secures Option to Acquire Radionetics for $1 Billion in Radiopharma Deal
Eli Lilly, Radionetics Oncology, Radiopharmaceuticals, G Protein-Coupled Receptors, Solid Tumors, Biotechnology, Acquisition
Rovi Receives Acquisition Offers for CDMO Unit Worth €2B to €3B
Rovi, CDMO, Acquisition Offers, Private Equity, Biogen, Deal Making
AbbVie Acquires Celsius Therapeutics for $250 Million, Expanding Inflammatory Disease Portfolio
AbbVie, Celsius Therapeutics, Acquisition, Inflammatory Diseases, M&A, Biotech
Day One Biopharma Expands Pipeline with $55 Million Acquisition of MabCare’s Phase 1-Ready ADC
Day One Biopharma, MabCare, Antibody Drug Conjugate (ADC), PTK7, Cancer Treatment, Biotech Acquisition, Pipeline Expansion
Asensus Surgical to be Acquired by KARL STORZ for $0.35 per Share in Cash
Asensus Surgical, KARL STORZ, acquisition, merger, surgical robotics, digital solutions, operating room, laparoscopy, LUNA system
AbbVie’s $10.1 Billion ImmunoGen Acquisition Bears Fruit with Elahere’s Mid-Stage Success in Ovarian Cancer Treatment
AbbVie, ImmunoGen, Elahere, Ovarian Cancer, Antibody-Drug Conjugate (ADC), Clinical Trial, Acquisition, Oncology
GSK Acquires Oligonucleotide Partner Elsie for Up to $50 Million
GSK, Elsie Biotechnologies, oligonucleotide platform, acquisition, biotech, pharmaceuticals
ArriVent Expands ADC Portfolio with $615 Million Alphamab Acquisition
ArriVent, ADC portfolio, Alphamab, acquisition, biotech, biotechnology, financing